Quality & Compliance: Regulatory Forces Shaping Biopharmaceutical QA/QC in 2010

| 01 June 2010

Over the last 10 years, I have presented my impressions of the impact of changing regulatory forces on biopharmaceutical quality assurance/quality control (QA/QC) in the 21st century.1,2 Today, changing regulatory forces at both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) continue to shape biopharmaceutical QA/QC in the following three ways:


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy